A DNA-based nanodevice for near-infrared light-controlled drug release and bioimaging

Qing Liu, Hong Bo Cheng, Rui Ma, Mingming Yu, Yuanyu Huang, Lele Li, Jian Zhao*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Abstract

DNA-based nanostructures have shown curative potential in drug delivery and anti-tumor therapy. However, the applications of such systems are limited by the lack of precise control over the space and duration of drug release. Here, we report a near-infrared (NIR) light-guided DNA nanodevice that enables controlled drug release for precise tumor imaging and therapy. The DNA nanodevice is constructed by engineering GC-rich DNA duplexes with an ultraviolet (UV) light labile moiety and further modification onto the surface of upconversion nanoparticles (UCNPs). The chemotherapeutic drug (doxorubicin, Dox) is intercalated into the GC motif of DNA duplexes, where the fluorescence signal of Dox is markedly quenched. Upon NIR light irradiation, the UCNPs acting as energy transducers emit UV light that can break the photolabile moiety in DNA duplexes, resulting in the controlled release of Dox and recovery of their fluorescence signal. We present that this DNA nanodevice is not only able to selectively induce tumor cells apoptosis via NIR light-mediated activation, but also enables in situ imaging and monitoring of drug release. Therefore, this modular strategy opens a window for remotely controlled drug delivery.

Original languageEnglish
Article number101747
JournalNano Today
Volume48
DOIs
Publication statusPublished - Feb 2023

Keywords

  • DNA nanodevice
  • Drug delivery
  • Near-infrared light
  • Tumor therapy
  • Upconversion nanoparticles

Fingerprint

Dive into the research topics of 'A DNA-based nanodevice for near-infrared light-controlled drug release and bioimaging'. Together they form a unique fingerprint.

Cite this